HomeHealth Care

Health Care

FDA to Review Expanded Use of Cancer Drug

Howard Fine - June 8, 2026

Health Care

Kin Health Raises $9 Million in Seed Funding

Howard Fine - June 8, 2026

Health Care

Amgen Drug Reviewed Amid Deaths

Howard Fine - May 25, 2026

Health Care

Atara Bounces Back with FDA

Howard Fine - May 18, 2026

Health Care

Johnese Spisso’s Mission in Medicine

Monée Fields-White - May 11, 2026

Health Care

Amgen Sees C-Suite Shifts

Howard Fine - May 4, 2026

Health Care

SprintRay Device Gets FDA Nod

Howard Fine - May 4, 2026

Health Care

Scanning for a $27 Billion Issue

Howard Fine - April 28, 2026

Health Care

Pair of New Health Care Initiatives Formed

Howard Fine - April 6, 2026

Health Care

Biotech Firm Gets a New Leader

Howard Fine - April 6, 2026

Health Care

MiniMed Circles Back

Howard Fine - March 30, 2026

Health Care

Herbalife Buys Assets of U.K. Firm for $55 Million

Howard Fine - March 30, 2026

Health Care

Strategy Pivot Hits GoodRx

Howard Fine - March 16, 2026

Health Care

DLP Eye Group Shutters

Howard Fine - March 11, 2026

Health Care

ImmunityBio’s Stock Sees a Huge Boost

Howard Fine - March 9, 2026

Health Care

USC Opens South L.A. Pharmacy

Howard Fine - March 9, 2026

Health Care

Bioscience: Curing Cuts

Howard Fine - February 16, 2026

Health Care

Origin Nets Series B Fundraise

Keerthi Vedantam - February 16, 2026

Health Care

New Sign-Off Propels ImmunityBio

Howard Fine - February 9, 2026

Health Care

Children’s Health Sees Development

Howard Fine - February 9, 2026

Health Care

New Surgical Site Nearing Completion

Howard Fine - February 9, 2026

Health Care

FDA Again Rejects Atara

Howard Fine - January 19, 2026

Health Care

Fulgent Will Acquire Two Laboratories

Howard Fine - January 12, 2026

Health Care

ImmunityBio, Xencor Drugs Win E.U. Nods

Howard Fine - January 12, 2026

Health Care

FDA to Review Expanded Use of Cancer Drug

Kin Health Raises $9 Million in Seed Funding

Amgen Drug Reviewed Amid Deaths

Atara Bounces Back with FDA

Johnese Spisso’s Mission in Medicine

Amgen Sees C-Suite Shifts

SprintRay Device Gets FDA Nod

Scanning for a $27 Billion Issue

Pair of New Health Care Initiatives Formed

Biotech Firm Gets a New Leader

MiniMed Circles Back

Herbalife Buys Assets of U.K. Firm for $55 Million

Strategy Pivot Hits GoodRx

DLP Eye Group Shutters

ImmunityBio’s Stock Sees a Huge Boost

USC Opens South L.A. Pharmacy

Bioscience: Curing Cuts

Origin Nets Series B Fundraise

New Sign-Off Propels ImmunityBio

Children’s Health Sees Development

New Surgical Site Nearing Completion

FDA Again Rejects Atara

Fulgent Will Acquire Two Laboratories

ImmunityBio, Xencor Drugs Win E.U. Nods

Advertise with Us

About Us

Membership Center

Other Journals